Tumorassociated macrophages block activity of chemotherapy drug in pancreatic cancer

Tumor-associated macrophages block activity of chemotherapy drug in pancreatic cancer

A frontline chemotherapy drug given to patients with pancreatic cancer is made less effective because similar compounds released by tumor-associated immune cells block the drug's action, research led by the University of Michigan Rogel Cancer Center found.

More From BioPortfolio on "Tumor-associated macrophages block activity of chemotherapy drug in pancreatic cancer"